cdmo.directory
← Compare landing

Cellipont Bioservices vs Omniabio

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/cellipont-bioservices/omniabio

CategoryCellipont BioservicesOmniabio
Listed sitecdmocdmo
SummaryCell therapy CDMO offering process development, analytical services, and cGMP manufacturing for CAR-T, TCR-T, allogeneic, autologous, and iPSC-derived therapies from preclinical through commercial stages.OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • Cell-Line Development
  • Process Development
  • CMC Analytical Development
  • Cell-Line Development
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Cell Therapy Manufacturing
  • Lentiviral Vector Manufacturing
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Cell Therapy
  • Gene Therapy
Indications
  • Oncology
Data not yet provided.
Locations
  • Headquarters & Manufacturing Facility, The Woodlands, Texas, United States
  • Headquarters & Manufacturing Facility, Hamilton, Ontario, Canada
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.